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Abstract 
Objectives: Renal cancer became a noticeable tumor recently with high 
mortality rates in the developed countries 
 The objective of this study to review the histopathological pattern of renal 
cancer and show the relationships between the histological type  , the 
clinical presentation , the mode of surgical procedure, grading the tumors 
by using Fuhrman grading and staging the tumors by using TNM staging 
system. 
Methods: This is a descriptive retrospective case series study of 108 adult 
renal cancer patients during the period from Jan 2007 to Aug 2010 from 
different histopathology departments in Khartoum state including Soba 
Teaching Hospital, IbnSina Hospital, Khartoum Teaching Hospital & 
National Health Laboratory. 
Data was collected from the patients request forms and patients files 
including detailed personal, clinical and pathological data. Formalin fixed 
paraffin embedded blocks of processed histopathology specimens were 
recut, stained and examined by the candidate and reviewed by the 
supervisor to determine the histopathological type, tumor grade and clinical 
stage of the patients.   
Results: The study included 108 patients, 59 were males and 49 females, 
with a   M: F ratio of 1.13:1.0. 
The youngest patient was 19 years and the eldest was 86 years.  
Thirty three patients (31.4%) were below 46 years with a mean age of 53 
years. The majority of patients were   from central regions. 
The clinical presentation included loin pain in 35.2%   (n=37), abdominal 
mass in 31.4% (n=34), hematuria in 22.9%   (n=24) and 4.8% (n=5) were 
incidental finding during ultra sound examination. 
Two   types of surgical procedures were performed:  nephrectomy and 
partial nepherctomy in 92 and 11 patients respectively. Eleven patients had 
needle biopsy only 
8 
 
Microscopic examination of the slides identified 7 histological types of renal 
cancer. These were clear cell RCC in 71.2%, papillary in 18%, sarcomatoid 
RCC in3.8%, Chromophobe in 0.9%, collecting duct RCC in 0.9%, 
transitional cell carcinoma in 4.5% and squamous cell carcinoma in 0.9% 
 Using Fuhrman grading system showed grade II, III, I and IV in 48, 29, 16 
and12 patients respectively 
TNM staging system showed stage III, II, I and IV in 41, 30,13and 8 
patients respectively. 
Conclusions:  Sudanese patients share many pathological and some of 
unique epidemiological features for renal cancer. 
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 ﻤﺴﺘﺨﻠﺺاﻟ
  
ﻳﻌﺘﺒﺮﺳﺮﻃﺎن اﻟﻜﻠﻲ ﻣﻦ اﻟﺴﺮﻃﺎﻧﺎت اﻟﺘﻲ ﺗﺘﻤﻴﺰ ﺑﻤﻌﺪﻻت وﻓﻴﺎت ﻋﺎﻟﻴﺔ وﻗﺪ أﺻﺒﺤﺖ ﻓﻲ اﻟﺴﻨﻮات : اﻷهﺪاف
هﺪﻓﺖ اﻟﺪراﺳﺔ إﻟﻲ ﻣﺮاﺟﻌﺔ اﻟﺘﻐﻴﺮات اﻟﻤﺮﺿﻴﺔ ﻓﻲ .اﻷﺧﻴﺮة ﻣﻦ اﻟﺴﺮﻃﺎﻧﺎت اﻟﺸﺎﺋﻌﺔ ﻧﺴﺒﻴًﺎ ﻓﻲ اﻟﺪول اﻟﻤﺘﻘﺪﻣﺔ 
ﻧﻤﻂ اﻟﻌﻼج ,اﻷﻧﺴﺠﺔ ﻓﻲ ﺳﺮﻃﺎن اﻟﻜﻠﻲ وﺑﺤﺚ ﻋﻼﻗﺔ اﻷﻧﻮاع اﻟﻨﺴﻴﺠﻴﺔ ﻟﻠﻮرم ﻣﻊ آﻞ ﻣﻦ ا اﻟﻌﻼﻣﺎت أﻟﺴﺮﻳﺮﻳﻪ 
  . درﺟﺔ اﻟﺘﺴﺮﻃﻦ واﻟﻤﺮﺣﻠﺔ اﻟﺴﺮﻳﺮﻳﺔ,اﻟﺠﺮاﺣﻲ
ﻣﻦ  801وﺳﻂ ﺟﺮﻳﺖﻋﻦ ﺳﺮﻃﺎﻧﺎت اﻟﻜﻠﻲ ﻋﻨﺪ اﻟﺴﻮداﻧﻴﻴﻦ أ ﻘﺼﺎﺋﻴﺔ وﺻﻔﻴﺔهﺬﻩ دراﺳﺔ إﺳﺘ :ﺤﺚﻣﻨﻬﺠﻴﺔ اﻟﺒ
. ﺑﻤﻌﺎﻣﻞ ﻣﺨﺘﻠﻔﺔ ﻓﻲ وﻻﻳﺔ اﻟﺨﺮﻃﻮم واﻟﺘﻲ ﺷﻤﻠﺖ م 0102ﺣﺘﻰ أﻏﺴﻄﺲ  7002ﻓﻲ اﻟﻔﺘﺮة ﻣﻦ ﻳﻨﺎﻳﺮ  اﻟﻤﺮﺿﻲ
  .اﻟﺨﺮﻃﻮم . اﺑﻦ ﺳﻴﻨﺎ، اﻟﻤﻌﻤﻞ اﻟﺼﺤﻲ اﻟﻘﻮﻣﻲ، م. ﺳﻮﺑﺎ اﻟﺠﺎﻣﻌﻲ ، م
  .ﺗﻢ ﺟﻤﻊ ﻣﻌﻠﻮﻣﺎت ﺳﺮﻳﺮﻳﺔ ﻣﻦ ﺳﺠﻼت اﻟﻤﺮﺿﻲ وﺗﻘﺎرﻳﺮهﻢ ﻓﻲ اﻟﻤﺴﺘﺸﻔﻴﺎت اﻟﻤﺬآﻮرة اﻋﻼة 
ﻗﻄﻊ وﺻﺒﻎ وﻣﺮاﺟﻌﺔ ﻋﻴﻨﺎت اﻟﻤﺮﺿﻰ اﻟﻤﺜﺒﺘﺔ ﻣﺴﺒﻘًﺎ ﺑﺎﻟﻔﻮرﻣﻠﻴﻦ واﻟﻤﻐﻤﻮرة ﻓﻰ اﻟﺒﺮﻓﻴﻦ وﻣﻦ ﺛﻢ ﺗﻢ  ﺗﻤﺖ إﻋﺎدة
ﺗﺤﺪﻳﺪ درﺟﺔ اﻟﺘﺴﺮﻃﻦ وﺗﺤﺪﻳﺪ اﻟﻤﺮﺣﻠﺔ اﻟﺴﺮﻳﺮىﺔ ﺑﻮاﺳﻄﺔ اﻟﺪارس وﻣﻦ ,ﺗﺸﺨﻴﺺ اﻻﻧﻮاع اﻟﻨﺴﻴﺠﻴﻴﺔ اﻟﻤﺨﺘﻠﻔﺔ
  اﺧﺘﺼﺎﺻﻲ اﻻﻧﺴﺠﺔ اﻟﻤﺸﺮف ﻋﻠﻲ اﻟﺒﺤﺚ  ﻣﻊﺛﻢ ﻣﺮاﺟﻌﺘﻬﺎ 
ﻟﻜﻞ ﻧﻮع ،  1: 31.1ﻣﻦ اﻹﻧﺎث ﺑﻨﺴﺒﺔ  94ﻣﻦ اﻟﺬآﻮر و 95ﻣﺮﻳﺾ آﺎن ﻣﻨﻬﻢ  801ﺗﻀﻤﻨﺖ اﻟﺪراﺳﺔ : اﻟﻨﺘﺎﺋﺞ
  .ﺳﻨﻪ  68ﺳﻨﺔ إﻟﻲ  91ﺖ أﻋﻤﺎر اﻟﻤﺮﺿﻲ ﻣﻦ وﺣوﺗﺮا
  %( 4.13) 33هﻨﺎﻟﻚ وﻗﺪ أﺑﺮزت اﻟﻨﺴﺒﺔ اﻟﻌﺎﻟﻴﺔ ﻟﻤﺮﺿﻲ ﺳﺮﻃﺎن اﻟﻜﻠﻲ ﻓﻲ اﻟﻔﺌﺎت اﻟﻌﻤﺮﻳﺔ اﻟﺼﻐﺮى ﺣﻴﺚ آﺎن
  .ﺳﻨﺔ 27.25ت هﻮ ﺳﻨﻪ وآﺎن ﻣﺘﻮﺳﻂ اﻟﻌﻤﺮ ﻟﻜﻞ اﻟﻔﺌﺎ 64ﻣﻦ اﻟﻤﺮﺿﻲ ﺗﺤﺖ ﻋﻤﺮ 
  .أﺷﺎرت اﻟﺪراﺳﺔ إﻟﻲ اﻟﻨﺴﺒﺔ اﻟﻌﺎﻟﻴﺔ ﻟﻠﻤﺮﺿﻲ اﻟﺬﻳﻦ ﻳﺴﻜﻨﻮن اﻟﻤﻨﺎﻃﻖ اﻟﻮﺳﻄﻲ ﻣﻦ اﻟﺴﻮدان
ﻣﻦ ورم  (33)4.13ﻣﻦ اﻟﻤﺮﺿﻲ ﻳﺸﻜﻮن ﻣﻦ أﻟﻢ ﻓﻲ اﻟﺨﺎﺻﺮة، (73)%  2.53وﺟﺪت اﻟﺪراﺳﺔ أن ﻧﺴﺒﺔ 
ﻓﻮق  ﺗﻢ اآﺘﺸﺎﻓﻬﻢ ﺑﺎﻟﺼﺪﻓﺔ ﻋﻨﺪ اﺟﺮاء ﻣﻮﺟﺎت( 5% )8.4ي وﻣﻦ اﻟﺒﻮل اﻟﺪﻣﻮ (42)%9.22.اﻟﺒﻄﻦ
  ..اﻟﺼﻮﺗىﺔ
أﻇﻬﺮت اﻟﺪراﺳﺔ ﺛﻼﺛﺔ أﻧﻮاع ﻣﻦ اﻟﻌﻴﻨﺎت هﻰ إﺳﺘﺌﺼﺎل اﻟﻜﻠﻴﻪ اﻟﻜﻠﻰ ، إﺳﺘﺌﺼﺎل اﻟﻜﻠﻴﻪ اﻟﺠﺰﺋﻰ  وﻋﻴﻨﻪ ﺻﻐﻴﺮة 
  %  .9.9،% 9.1، %6.78ﻋﻦ ﻃﺮﻳﻖ اﻟﺠﻠﺪ وآﺎﻧﺖ اﻟﻨﺴﺐ ﻋﻠﻰ اﻟﺘﻮاﻟﻰ  
ﻠﻮﻳﺔ وﻣﻨﻬﺎ اﻟﻔﺤﺺ أﻟﻤﺠﻬﺮي ﻟﻠﺸﺮاﺋﺢ وﺻﻞ إﻟﻲ ﺳﺒﻌﻪ أﻧﻮاع ﻧﺴﻴﺠﻴﻪ ﻣﻦ ﺳﺮﻃﺎن اﻟﻜﻠﻲ هﻲ ﺳﺮﻃﺎﻧﻪ اﻟﺨﻠﻴﺔ اﻟﻜ
، اﻟﻨﻮع اﻟﻼﺻﺒﻮﻏﻲ  %  8.3، اﻟﻨﻮع اﻟﻐﺮاوﻧﻲ %  81ﻣﻦ اﻟﻨﻮع اﻻﻋﺘﻴﺎدي ،أﻟﺴﺮﻃﺎﻧﻪ اﻟﺤﻠﻴﻤﻴﻪ %  2.17
  % .9.0، اﻟﺴﺮﻃﺎﻧﺔ اﻟﺼﺪﻓﻴﺔ %  4.5،ﺳﺮﻃﺎﻧﺔ اﻟﺨﻼﻳﺎ اﻟﻤﺘﺤﻮﻟﺔ %  9.0، ﺳﺮﻃﺎﻧﺔ اﻟﻘﻨﻮات اﻟﺠﺎﻣﻌﺔ % 9.0
ﺟﺔ اﻻﻧﺘﺸﺎر اﻟﻲ ارﺑﻌﺔ ﻣﺮاﺣﻞ ﺣﺴﺐ ﺣﺠﻢ اﻟﻮرم ودر( MNT)أﻇﻬﺮت اﻟﺪراﺳﺔ اﻟﻤﺮاﺣﻞ اﻟﺴﺮﻳﺮﻳﺔ ﻟﻠﻤﺮض 
  .ﻣﺮﺿﻲ 8ﻣﺮﻳﺾ واﺧﻴﺮا اﻟﻤﺮﺣﻠﺔ اﻟﺮاﺑﻌﺔ  31اﻻوﻟﻲ ,ﻣﺮﻳﺾ  03ﻣﺮﻳﺾ ﺛﻢ اﻟﺜﺎﻧﻴﺔ  14اﻟﻤﺮﺣﻠﺔ اﻟﺜﺎﻟﺜﺔ : 
ﻴﺔ ﻤﺮﺿﻲ اﻟﺴﻮداﻧﻴﻴﻦ ﻳﺸﺘﺮآﻮن ﻣﻊ اﻟﻤﺮﺿﻲ ﻓﻲ اﻟﻌﺎﻟﻢ ﻓﻲ اﻟﻌﺪﻳﺪ ﻣﻦ اﻟﺨﺼﺎﺋﺺ اﻟﻮﺑﺎﺋﻴاﻟ: اﻟﺨﻼﺻﺔ
  .واﻻﻣﺮاﺿﻴﺔ ﻟﺴﺮﻃﺎن اﻟﻜﻠﻲ
وذﻟﻜﻠﻼآﺘﺸﺎﻓﺎﻟﻤﺒﻜﺮ ﺧﺘﺼﺎﺻﻴﻦ  واﻟﻤﺮﺿﻲ ﻋﻦ ﺳﺮﻃﺎن اﻟﻜﻠﻲ ﻟﺘﻮﻋﻴﺔ اﻟﻘﺼﻮى ﻟﻼأﺷﺎرت اﻟﺪراﺳﺔ اﻟﻲ أهﻤﻴﺔ ا
  .واﻟﻮﺻﻮل إﻟﻲ ﻣﻌﺪﻻت اﻣﺮاﺿﻴﺔ ووﻓﺎة أﻗﻞ
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INTRODUCTION AND LITERATURE REVIEW 
Malignant tumors of the kidney constitutes agroup of tumors that are highly 
heterogeneous with respect to morphology and clinical behavior. 
Renal cell carcinoma account for 85% of renal cancer in adults and 
represent about 3% of adult malignancies.(1) 
Renal cell carcinoma is found among all ethnic groups and geographic 
areas .With the highest incidence reported in north America and  northern 
Europe and the lowest incidence in  Asian countries and areas of central 
and south America. There is a higher incidence among blacks than whites 
in the United States. Men are more affected than women in a ratio of about 
2:1 in the sixth and seventh decades of life.(5) 
The most important etiologic factor for RCC is cigarette smoking.(11)Other 
environmental factors, nutritional and cytogenetic abnormalities are also 
established etiological factors. There is also increased incidence in patients 
with chronic renal failure and acquired cystic diseases. Autosomal 
dominant familial renal cancers account for only 4%, and they are common 
in younger individuals. 
In Sudan, there are no published data on renal cancers. So, this study is 
designed to analyze the clinico-pathological patterns of renal cancer among 
adult Sudanese patients from different departments of pathology at 
Khartoum state during the period between 2007 to August 2010. 
 
1-1 Normal anatomy and histology of the kidney 
1-1-1 Anatomy  
The kidneys are two somewhat bean-shaped, reddish-brown organs 
located in the retroperitoneal space on either side of the vertebral column. 
Each kidney weighs about 150 gms, measures 11 cm long and 6 cm wide 
and lies between T11-12 and L3. Each kidney has a convex lateral border 
and a concave medial border with the two borders merging at the poles  
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superior and inferior portions). Surrounding each organ is the fibrous renal 
capsule, which is loosely adherent to it. Adipose tissue surrounds the 
capsule and is in turn surrounded by the renal fascia (Gerota's fascia), 
which secures the kidney to the posterior abdominal wall. Much of the 
medial border is occupied by an indentation, the hilum, through which the 
renal vessels, nerves, lymphatics and the renal pelvis enter or leave the 
renal sinus, the space enclosed by the renal parenchyma. 
The bisected kidney through the hilum shows the parenchyma to consist of 
an outer cortex, which forms a continuous subcapsular band of tissue, and 
an inner medulla, which is discontinuous being interrupted by projections of 
the cortex towards the renal sinus, the renal columns (columns of Bertin). 
The medulla consists of several triangular structures, the pyramids, with 
their bases towards the cortex and their tips, called papillae, projecting into 
minor calyces. (2) 
1-1-2 Blood Supply 
The kidney is richly supplied by blood vessels as they receive about 25% of 
cardiac output. The cortex is receiving 90% of the total renal blood supply. 
The main renal artery divides into anterior and posterior sections at the 
hilum. From these, inter lober arteries emerge, course between lobes, and 
give rise to the arcuate arteries, which arch between cortex and medulla, in 
turn giving rise to the interlobular arteries. From the interlobular arteries, 
afferent arterioles enter the glomerular tuft, where they progressively 
subdivide into 20 to 40 capillary loops arranged in several units or lobules 
architecturally centered by supporting mesangial stalk. Capillary loops 
merge to exit from the glomerulus as efferent arterioles. In general, efferent 
arterioles from superficial nephrons form a rich vascular network that 
encircles cortical tubules (peritubluar vascular network), and deeper 
juxtamedullary glomeruli give rise to the vasa recta, which descend as 
straight vessels to supply the outer and inner medulla. These descending 
arterial vasa recta then make several loops in the inner medulla and 
ascend as the venous vasa recta. (6)  
1-1-3 Histology  
The renal parenchyma is composed of functional units called the nephron, 
and connective tissue, the interstitium.Each nephron consists of a tuft of 
anastomosing capillaries called the glomerulus, formed from the afferent 
arteriole and draining into the efferent arteriole, and a tubular system called  
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the renal tubule. Epithelial cells called podocytes (or visceral epithelium of 
Bowman's capsule) invest the glomerulus, and are reflected to become 
continuous with the parietal epithelium of the Bowman's capsule. The 
Bowman's capsule is the bulbous, distended, closed proximal end of the 
tubular system and is invaginated by the glomerulus. The space between 
the glomerulus and capsule is the urinary space. Extending from the 
capsule is the proximal tubule, which is lined by tall cuboidal-to-columnar 
epithelial cells containing many mitochondria and a prominent brush 
border. The proximal tubule is the longest portion of the tubular system and 
is made up of convoluted proximal and distal straight (pars recta) 
segments. The pars recta descend into the medulla, where it forms the U-
shaped loop of Henle. The latter reenters the cortex within which it forms 
the straight and convoluted segments of the distal tubule. The distal tubule, 
at about the junction between its two segments, runs close to the 
glomerular hilum and forms a specialized segment called the macula densa 
(see below). The distal tubule is lined by cuboidal epithelium that lacks a 
brush border.  The distal tubule empties into collecting tubules, which in 
turn drain into collecting ducts. The latter converge, as they approach the 
medulla, to form the collecting ducts of Bellini, which run vertically through 
the medulla to the papillae. The collecting tubules and ducts are lined by 
pale-staining, cuboidal epithelial cells called clear cells scattered amongst 
which are darker-staining intercalated cells. The straight portions of the 
proximal and distal tubules and the collecting ducts run in parallel arrays in 
a portion of the cortex devoid of glomeruli and inaccurately called the 
medullary rays (because they appear to emanate from the medulla). The 
medullary ray and the glomeruli and convoluted tubules on either side of it 
form the cortical subunit, the lobule.  The interstitium is made up of the 
interstitial cells, which are fibroblast-like, and matrix. In the cortex the 
interstitium is small and mainly occupied by small blood vessels and 
lymphatics and, at the hilum of glomeruli, lacis cells. However, in the 
medulla it increases considerably in amount. The lacis cells, together with 
the macula densa and specialized myoepithelial cells in the walls of 
afferent and efferent arterioles containing neurosecretory granules filled 
with renin form the juxtaglomerular apparatus.(2) 
1-2 Renal Pathology 
1-2-1 Congenital Anomalies 
About 10%of all people are born with malformations of the urinary system.(3 
Structural anomalies of the kidney include: 
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a) Agenesis of the kidney. 
b) Renal hypoplasia. 
c) Ectopic kidney. 
d) Horseshoe kidney. 
1-2-2 Cystic diseases of the kidney 
Cystic diseases of the kidney are a heterogeneous group comprising 
hereditary, developmental and acquired disorders. 
Classification of renal cysts is as follows: 
 1) Cystic renal dysplasia. 
2) Polycystic kidney disease 
      a) Autosomal dominant (adult) 
      b) Autosomal recessive (child hood) 
3) Medullary cystic disease 
      a) Medullary sponge kidney 
      b) Nephronphthisis 
4) Acquired (dialysis associated) cystic disease 
5) Localized (simple)renal cysts 
6) Renal cysts in hereditary malformation syndromes (e.g, tuberous 
sclerosis) 
7) Glomerulocystic disease 
8) Extraparenchymal renal cysts (pyelocalyceal cysts , hilar lymphangiatic 
cysts)(4) 
1-2-3  Non Neoplastic Renal Diseases 
Glomerular diseases 
Glomerular diseases constitute some of the major problem in nephrology; 
chronic glomerulo nephritis is one of the most causes of chronic renal 
failure in humans. 
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The glomerular diseases are classified as: 
1) Primary  glomerulophathies, in which the kidney is the only or 
predominant organ involved. It constitute various types including: acute 
diffuse proliferative glomerulonephritis, rapidly progressive (crescentic) 
glomerulonephritis, membranous glomerulopathy, minimal change disease, 
focal segmental glomerulosclerosis, membranoproliferative 
glomerulonephritis, IgA nephropathy and chronic glomerulo nephritis. 
2) Secondary glomerular diseases, in which the kidney is injured by a 
variety of factors and in the course of a number of systemic diseases eg, 
systemic lupus erythermatosis, vascular disorders such as  hypertension 
and polyarteritis nodosa, metabolic diseases such as diabetes mellitus, and 
some hereditary conditions such as Fabry disease.(5) 
Diseases affecting tubules and interstitium 
This includes: 
1) Ischemic or toxic tubular injury that leading to acute tubular necrosis and 
acute renal failure. 
2) Inflammatory reactions of the tubules and interstitium (tubulointerstitial 
nephritis). 
3) Other tubulointersitial diseases, eg , urate nephropathy, hypercalcemia,  
nephrocalcinosis  & multiple myeloma. 
Diseases of blood vessels 
Nearly all diseases of the kidney involve the renal blood vessels 
secondarily. Systemic vascular diseases, also affect the renal vessels, this 
includes: 
? Benign nephrosclerosis. 
? Malignant hypertension and accelerated nephrosclerosis. 
? Thrombotic Microangiopathies. 
? Renal artery stenosis. 
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Obustrucive diseases 
? Obustructive uropathy. 
? Urolithiasis(renal stones).(5)(6)   
 
1-3  WHO classification of kidney tumors  
 
Renal cell tumours 
Clear cell renal cell carcinoma 8310/31 
Multilocular clear cell renal cell carcinoma 8310/3 
Papillary renal cell carcinoma 8260/3 
Chromophobe renal cell carcinoma 8317/3 
Carcinoma of the collecting ducts of Bellini 8319/3 
Renal medullary carcinoma 8319/3 
Xp11 translocation carcinomas 
Carcinoma associated with neuroblastoma 
Mucinous tubular and spindle cell carcinoma 
Renal cell carcinoma, unclassified 8312/3 
Papillary adenoma 8260/0 
Oncocytoma 8290/0 
Metanephric tumours 
Metanephric adenoma 8325/0 
Metanephric adenofibroma 9013/0 
Metanephric stromal tumour 8935/1 
Nephroblastic tumours 
Nephrogenic rests 
Nephroblastoma 8960/3 
Cystic partially differentiated nephroblastoma 8959/1 
Mesenchymal tumours 
Occurring Mainly in Children 
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Clear cell sarcoma 9044/3 
Rhabdoid tumour 8963/3 
Congenital mesoblastic nephroma 8960/1 
Ossifying renal tumour of infants 8967/0 
Occurring Mainly in Adults 
Leiomyosarcoma (including renal vein) 8890/3 
Angiosarcoma 9120/3 
Rhabdomyosarcoma 8900/3 
Malignant fibrous histiocytoma 8830/3 
 Haemangiopericytoma 9150/1 
Osteosarcoma 9180/3 
Angiomyolipoma 8860/0 
Epithelioid angiomyolipoma 
Leiomyoma 8890/0 
Haemangioma 9120/0 
Lymphangioma 9170/0 
Juxtaglomerular cell tumour 8361/0 
Renomedullary interstitial cell tumour 8966/0 
Schwannoma 9560/0 
Solitary fibrous tumour 8815/0 
Mixed mesenchymal and epithelial tumours 
Cystic nephroma 8959/0 
Mixed epithelial and stromal tumour 
Synovial sarcoma 9040/3 
Neuroendocrine tumours 
Carcinoid 8240/3 
Neuroendocrine carcinoma 8246/3 
Primitive neuroectodermal tumour 9364/3 
Neuroblastoma 9500/3 
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Phaeochromocytoma 8700/0 
 
Haematopoietic and lymphoid tumours 
Lymphoma 
Leukaemia 
Plasmacytoma 9731/3 
Germ cell tumours 
Teratoma 9080/1 
Choriocarcinoma 9100/3 
Metastatic tumours 
  
1-4 Epidemiology & risk factors of renal cancer 
1-4-1 Epidemiology 
Renal cancer accounts for about 2% of all cancers. And around 208,500 
new cases are diagnosed each year. (8) 
The incidences varies widely, with the highest rates being in North America  
and Scandinavia. There is higher incidence among blacks than whites in 
the United States. Estimated new cases and deaths from kidney and renal 
pelvis cancer in the U.S in 2010 :( 9) 
New cases 58,240 Deaths 13,040 
Renal cell carcinoma represents 85% of renal parenchymal malignancies. 
Among urologic tumors it is the worst in cancer specific mortality, since 
more than 40% of the patients with RCC die of the disease.(10) RCC may 
occur at any age, with peak incidences in the sixth and seventh decades of 
life .They occur twice as frequently in men as in women. 
1-4-2 Risk Factors 
Environmental factors play a significant role in the development of renal 
cancers. 
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1) Tobacco ,whether smoked or chewed ,heavy smoking double the risk of 
RCC, directly  related  with the number of cigarettes and inversely with age 
of beginning of the habit.(11) 
2) Obesity, particularly in women, increased the risk up to 5 fold higher risk 
in those with highest 5 percent body mass index compared with lowest 
quartile.(12) 
3) Hypertension has been identified as a significant risk factor. Despite the 
exact mechanism is not known (13), it seems that metabolic and/or 
functional changes in the renal tubular cells produce carcinogenesis. 
4) Chemical  
Cadmium was demonstrated to have influence on the development of RCC 
in cigarettes smokers (14) .The well known chemicals associated with RCC 
are: 
? Asbestos increases the risk of RCC especially in insulation workers 
and asbestos products workers, where it found to be deposited in 
kidney tissue.(15-16) 
? Organic solvents, pesticides, copper sulphate .benzene herbicides, 
and vinyl chloride increased risk of RCC in prolonged exposure.(17) 
? Polycyclic aromatic hydrocarbons e.g. Coal oven workers and 
firefighters.(18) 
5) Estrogen therapy in post menopausal women’s and as contraceptives. 
6) Diuretics: there are high incidences of RCC in patients with chronic 
intake of diuretics. (19-20-22) 
7) Analgesics: although this is a controvertered topic, several studies 
reported increase the risk of RCC with the use of analgesics like 
parcetamol, salicylates and phenacetin.(23-24) Drugs that contain 
phenacetin, increase the risk for transitional cell carcinoma of the renal 
pelvis. 
8) Radiations: Ionizing radiation appears to increase the RCC among 
patients treated for ankylsoing spondylites and cervical cancer. (25-26)  
Other less recognized risk factors include: 
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? Viruses, especially immune suppressant state in HIV.(27) 
? Dietary studies have generally found reduced risk with increased 
consumption of fruits and vegetables.(28) 
? Alteration in development of the kidney eg, horse shoe kidney.(29-30) 
1-4-3 Hereditory causes 
Most of the cases of RCC are sporadic; however there are some defined 
types of RCC with a hereditary pattern. 
(1) Von Hippel-Lindau (VHL) disease  
The VHL disease is inherited through an autosomal dominant trait. The 
syndrome is caused by germline mutations of the VHL tumor suppressor 
gene, located on chromosome 3p25-26; these mutations can virtually 
always be identified. The VHL protein takes part in cell cycle regulation and 
angiogenesis.(31) Patients develop capillary haemangioblastomas of the 
central nervous system and retina, clear cell carcinoma, 
phaeochromocytoma, pancreatic, and inner ear tumors. 
The clinical diagnostic criteria of VHL disease consist of: 
i. Presence of capillary haemangioblastoma in the central nervous 
system or retina.  
ii. Presence of one of the typical VHL associated extra neural tumors, 
within pertinent family history. 
Fourty to sixty percent of the patients with VHL disease present with RCC. 
Although they are usually low-grade tumors, the progress rate to 
metastasis is around 30 %.(32) 
Renal lesions in carriers of VHL germline mutations are either cysts or clear 
cell RCC. They are typically multifocal and bilateral. 
(2) Hereditary papillary renal carcinoma  
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This type of renal carcinoma is an inherited tumor syndrome with 
autosomal dominant trait and of late onset, with multiple and bilateral 
papillary renal cell carcinomas type 1. (33)The disease is caused by  
activating mutations of the MET oncogene which maps the chromosome 
7q31. 
(3) Hereditary leiomyomatosis and renal cell carcinoma  
This is an autosomal dominant tumor syndrome with germline mutations in 
the FH gene (chromosome lq42.3–q43), These patients have the tendency 
to acquire benign leiomyomas of the skin and the uterus, and occasionally 
papillary renal cell carcinoma type 2 and uterine leiomyosarcomas.(34) 
(4) Birt-Hogg-Dube syndrome  
This syndrome is characterized by benign skin tumors, specifically 
fibrofolliculomas, trichodiscomas, and acrochordons. Multiple renal tumors 
and spontaneous pneumothoraces are also frequent.(35) We can find 
chromophobe RCC, typical RCC, hybrid oncocytoma, papillary RCC, or 
oncocytic tumors. 
The Birt-Hogg-Dube gene maps the chromosome 17p11.2 and encodes 
the protein called folliculin. This gene is also involved in sporadic RCC. 
(5) Familiar clear cell renal cell carcinoma  
These families present a hereditary form of multiple, bilateral clear cell 
RCC but without any clinical evidence of suffering the von Hippel-Lindau 
disease.(36) 
This hereditary cancer is characterized to present translocations affecting 
the chromosome 3. Translocations have been described among the 
chromosome 3 and the 8, 6, 2, 1& 4.   
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 Acquired cystic disease/chronic dialysis 
Approximately the 35 to 47% of the patients on dialysis and specially those 
with a very long history present acquired cystic disease (37). Some patients  
with this disease develop a papillary hyperplasia in the epithelium of the 
cysts that would be the origin of the RCC. 
Approximately the 5 to 9% of the patients with acquired cystic disease will 
develop an RCC, showing a higher incidence in population.(38) 
 
1-5  Localization of renal cancer 
The RCC; putative cell of origin and genetics correlation (39) 
 
 
 
 
 
 
 
 
 
 
                 
            
  
                                                 . 
                                                          
Proximal Nephron
Papillary RCC   genetic +, 17+, 
3+, Y- and t(x; 1), (x; 17) 
Clear cell RCC 
genetic 3p- 
Cells of the distal 
convoluted tubule 
Cells of the proximal 
convoluted tubule 
Distal Nephron 
Intercalated cells 
of the renal cortex 
Tubular & spindle 
cell 1-,4q-,8-.11q-
,13-,17+,20q+ 
Loop of Henle or 
collecting ducts 
Chromophobe RCC 
Y-,1-,2-,6-,10-,17-,21- 
Medullary 
carcinoma 
(sickle) cell) 
Collecting duct 
carcinoma 1-,6-
,14-,22-.13q- 
Collecting ducts of 
the renal medulla    
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1-6 Metastasis and spread of renal cancer 
Renal cell carcinoma have higher propensity for extensive venous invasion,  
which is more common in clear cell type (18-29%).Extension of the tumor 
into  the renal vein is one of the   common features of the disease is it’s 
tendency to metastatize hematogenously before giving rise to local 
symptoms and signs.(2) 
The most common localizations of  distant metastasis are the lungs (where 
canon ball secondary tumors are produced) , with regional lymph nodes , 
liver, and bone showing about equal frequencies, next followed  by the 
adrenal, the other kidney and the brain .Un usual sites for metastasis  
include nasal cavity, parotid, heart, thyroid, pituitary, and genital organs.(40) 
1-7 Diagnoses 
1-7-1 Clinical picture of renal cancer 
The majority of patients with renal cell carcinoma are asymptomatic.50%of   
cases are now detected incidentally (radiologist tumor) (41) 
The symptoms and signs include: triad of RCC haematuria40%, pain40% 
and flank mass25%.  A combination of all three components of the 
(classical triad) occurs in less than 10% of cases. (42) Other non specific 
symptoms include weight loss, fever, fatigue, nausea, vomiting, and 
varicocele (left sided) secondary to obstruction of the spermatic vein is 
observed in a few patients. 
Hepatomegally that is associated with hepatic dysfunctions in patients with 
RCC is known as Stauffer syndrome, where the main morphological 
change in the liver is sinusoidal dilation. 
RCC is associated with para neoplastic syndrome in form of polycythemia, 
hypercalcemia, Cushing,s syndrome, and neuropathy. (43) 
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1-7-2 Diagnostic strategy 
 Detailed medical review of past health state  
One of the first steps in establishing a renal cell carcinoma diagnosis is a detailed
and complex medical review of a patient's past health problems and general 
health state, family medical history, kidney cancer risk factors, and symptoms. 
Physical examination:  
During a physical examination, look for noticeable signs of the kidney cancer 
such as the high body temperature, high blood pressure, the presence of any 
large tumor in the abdominal cavity.
  
Laboratory tests 
Urine tests: These set of tests check for several indicators of the cancer 
such as blood, sugar, proteins, and bacteria.  
Blood tests: These set of tests measure the amount of several kidney 
cancer indicators, (red blood cells and creatinine). 
Imaging Techniques 
Ultrasonography: the initial investigation as it safe, non invasive, and 
fastest procedure. (41) 
Compouted tomography scan: Sensitivity of 78%.it is used for tumor 
detection and involvement of renal vein and inferior vena cava. 
Magnetic resonant imaging (MRI): It reveal the complete image of the 
kidneys and are indicated in local advanced malignancy, venous 
involvement, renal insufficiency, and distinguish tumor thrombus from bland 
thrombus. (44) 
Positron emission tomography (PET scan): For detection of metastases. 
Bone scan: Used for symptomatic patients or patients with abnormal 
alkaline phosphatase. 
Others like intra venous pyelography, chest x .ray, and angiography.  
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1-7-3 Pathological diagnoses 
 
Imaging studies usually provide enough information for a surgeon to decide 
if an operation is needed. However, fine needle aspiration (FNA) biopsy or 
needle core biopsy is sometimes used to get a small sample of cells from a 
suspicious area if imaging test results are not conclusive enough to warrant 
removing a kidney. Biopsy may also be done to confirm the diagnosis of 
cancer if a person's health is too poor for surgery and other local 
treatments (such as radiofrequency ablation, arterial embolization or 
cryotherapy) are being considered. (45) 
Fine needle aspiration and needle core biopsy are 2 types of percutaneous 
kidney biopsy. 
 
1-8 Renal tumors 
1-8-1 Benign renal tumors 
i. Papillary adenoma 
Grossly, papillary adenomas are yellow to pale nodules within the renal 
cortex. Histologically  , the tumours show varying proportions of papillary 
and tubular architecture .The cytoplasm is usually scant and mitotic figures 
are rare ,Foamy macrophages and psammoma bodies are common .There 
may be a pseudocapsule. (46) 
Papillary adenomas show lower proliferative activity than both papillary and 
clear cell renal cell carcinomas. Some studies have found that papillary 
adenomas frequently have trisomy of chromosomes 7 and 17 and loss of 
the Y chromosome in males.(15) Positive immune histochemical reactions 
for cytokeratins and vimentin in papillary adenoma. 
 
ii.  Metanephric adenoma and adenofibroma 
 
Metanephric adenomas are rare epithelial tumours ( < 1% of renal cell 
neoplasms) that occur at any age and are more common in females. These 
tumours  are variable in size, ranging up to 15 cm in diameter. The cut 
surface is fleshy and is grey to yellow, often with areas of cystic change 
and haemorrhage. 
Histologically,  metanephric adenomas consist of small tubules with 
occasional blunt papillae reminiscent of glomeruli . Psammoma bodies are 
common. Unlike papillary renal carcinoma, metanephric adenomas are 
rarely multifocal , are not associated with renal scarring, and usually lack a  
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pseudo capsule. They are also of uniformly low grade with small nuclei, 
inconspicuous nucleoli, and rare or absent mitotic figures. 
Metanephric adenoma appears to be related to two other entities, 
metanephric  adenofibroma and metanephric stromal tumor.  
Metanephric adenofibroma (originally called ‘nephrogenic adenofibroma’) 
is a rare tumour originally considered to be related to mesoblastic 
nephroma and nephroblastomatosis. (47)  
The tumour consists of nests of epithelial elements identical to metanephric 
adenoma surrounded by bands and sheets of fibroblast-like spindle cells . 
Metanephric  stromal tumour appears related to metanephric adenofibroma 
but is composed entirely of the stromal component . These recently 
described tumours are frequently CD34-positive and appear benign. 
. 
iii.  Renal Oncocytoma 
 
Oncocytomas are well-circumscribed and are frequently brown, both when 
fresh and when fixed in formalin. A central stellate zone of oedematous 
stroma is common but non-specific. Multifocality occurs in 13% and 
bilaterality in 4–5% of cases.  Rarely, numerous oncocytic nodules are 
present within the same kidney, sometimes exhibiting a spectrum of 
histological features ranging from oncocytoma to chromophobe renal 
carcinoma. (58) 
Histologically, oncocytomas most often show solid growth with delicate 
inconspicuous vasculature and microcystic growth pattern. 
. As is characteristic of oncocytes in general, the cells have voluminous 
eosinophilic cytoplasm, although clusters of smaller cells and pyknotic cells 
are fairly common. Scattered cells with pronounced nuclear pleomorphism, 
including multinucleated giant cells, are also seen in oncocytoma. Mitotic 
activity is absent or rare. Microscopic infiltration into peri renal fat is 
occasionally present and intravascular extension has been reported. 
Oncocytomas appear to originate in the intercalated cells of collecting duct 
epithelium. 
Several genetic abnormalities are frequent in oncocytoma: loss of 
chromosomes 1 and Y, translocations involving breakpoint 11q13, and a 
variety of chromosomal abnormalities. 
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iv. Angiomyolipoma  
Angiomyolipomas are benign lesions characterized by the presence of 
mature adipose tissue, smooth muscle and thick-walled blood vessels. The 
true nature of these lesions is uncertain, but they are usually regarded as 
hamartomas. About 33% of patients with angiomyolipoma have tuberous 
sclerosis and more than 80% of tuberous sclerosis patients have 
angiomyolipoma. 
Typically, the lesions are asymptomatic but may present with flank pain, 
mass, hematuria or a combination of these especially in patients with 
tuberous sclerosis. Grossly, the tumors are typically multifocal, bilateral and 
small in patients with tuberous sclerosis, and single, unilateral and large in 
those without. They are well circumscribed but not encapsulated and have 
varied appearances depending on the proportions of the constituent 
elements. In 25% of cases the tumors may be confused with malignancy 
because of extension outside the renal capsule 
The tumors show a wide variation in microscopic appearances due to 
differences in the amount of each component present in a particular tumor. 
There is no definite organization and the three components are 
haphazardly arranged. The bizarre mixture of elements may lead to 
confusion with malignant tumors. 
v. Juxtaglomerular Cell Tumor  
This is a rare, usually benign neoplasm of the juxtaglomerular cells of the 
kidney. Clinically, they occur mainly in young people, all of whom present 
with hypertension. Grossly, the tumors are small, usually less than 3 cm in 
diameter, well circumscribed and located in the cortex. Histologic 
appearances are variable 
1-8-2 Malignant renal cell tumors 
 
Renal Cell Carcinoma 
1- Clear cell RCC 
Clear cell renal cell carcinoma comprises approximately 70% of malignant 
renal cell neoplasms.(48). 
Most clear cell RCC are solitary cortical neoplasms that occur with equal 
frequency in either kidney. Multicentricity (4%) and bilateralism (0.5 to 
3.0%) may be seen. The size is variable, but the frequency of small lesions 
increases due to imaging techniques. Clear cell RCC is typically golden 
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yellow. Necrosis, cystic degeneration, hemorrhage calcification, ossification 
(49) 
 
Histology 
Clear cell RCC is architecturally diverse, with solid, alveolar and acinar 
patterns, the most common. The carcinomas typically contain a regular 
network of small thin-walled blood vessels, a diagnostically helpful 
characteristic of this tumour. No lumens are apparent in the alveolar pattern 
but a central, rounded luminal space filled with lightly acidophilic serous 
fluid or erythrocytes. The alveolar and acinar structures may dilate, 
producing microcystic and macrocystic patterns(50) Infrequently, clear cell 
renal cell carcinoma has a distinct tubular pattern and 
rarely a pseudopapillary architecture is focally present. The cytoplasm is 
commonly filled with lipids and glycogen, which are dissolved in routine 
histologic processing, creating a clear cytoplasm surrounded by a distinct 
cell membrane. Many tumours contain minority populations of cells with 
eosinophilic cytoplasm; this is particularly common in high grade tumours 
and adjacent to areas with necrosis or haemorrhage. In well preserved 
preparations, the nuclei tend to be round and uniform with finely granular, 
evenly distributed chromatin. Depending upon the grade, nucleoli may be 
inconspicuous, small, or large and prominent. Very large nuclei lacking 
nucleoli or bizarre nuclei may occasionally occur. (52-53) 
 
Immunoprofile 
Clear cell  RCCs frequently react with antibodies to brush border antigens, 
low molecular weight cytokeratins, CK8,CK18, CK19, AE1, Cam 5.2 and 
vimentin. 
The majority of clear cell RCCs react positively for renal cell marker , CD10 
and epithelial membrane antigen  . MUC1 and MUC3 are consistently 
expressed . 
 Extension into the renal vein and sarcomatoid change may occur.  
The term ‘‘granular cell’’ indicates RCC with acidophilic cytoplasm.   Micro 
vascular invasion might be a relevant clinical prognostic parameter for low 
clinical stage RCC and could be the only independent predictor of disease-
recurrence after radical surgery. Sarcomatoid change may be seen in all 
types of RCC with no evidences supporting that RCC develops ‘‘de novo’’ 
as sarcomatoid carcinoma. Clear cell RCC has a worse prognosis when 
compared with Chromophobe or papillary subtypes. However, the response 
rate to systemic therapy is higher than other histological types. 
Fuhrman nuclear grade after stage is the most important prognostic 
predictor in RCC. 
Sporadic clear cell RCC displays frequent chromosome 3p losses.   
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2- Multilocular cystic renal cell carcinoma (MCRCC) 
This is a tumor with excellent outcome and entirely composed of cysts of 
variable size separated from the kidney by a fibrous capsule. The cyst are 
lined by a single layer of clear to pale cells but occasionally shows a few 
small papillae. The septa are composed of fibrous tissue that may have 
epithelial cells with clear cytoplasm that resemble those lining the cysts. 
VHL gene mutations in MCRCC support its classification as a type of clear 
cell RCC(54). There is a male predominance of3:1 with age ranging 20 to 76 
years. No progression of MCRCC has been observed. 
 
3- Papillary renal cell carcinoma (PRCC) 
PRCC has a less aggressive clinical course than clear cell RCC. PRCC 
has variable proportions of papillae and may be bilateral or multifocal with 
frequent hemorrhage, necrosis and cystic degeneration. The papillae 
contain a fibro vascular core with aggregates of foamy macrophages, 
calcified concretions and frequent hemosiderin granules.(56) Cellular type 1 
and type 2 tumors have been recognised with papillae covered by small 
cells with scanty cytoplasm arranged in a single layer in type 1, and tumor 
cells of higher nuclear grade, eosinophilic cytoplasm and pseudostratified 
nuclei in type 2. Trisomy or tetrasomy 7, trisomy 17 and loss of 
chromosome Y are the earliest karyo typic change. Fuhrman’s tumor 
grade, stage, tumor proliferation and sarcomatoid change being correlated 
with outcome. Type 1 tumors have longer survival.  
 
4- Chromophobe RCC 
Characterized by huge pale cells with reticulated cytoplasm and prominent 
cell membrane. It accounts for 5% of renal epithelial tumors. Chromophobe 
RCC is solid and appears orange turning grey or sandy after fixation. When 
the cytoplasm is pale, the cytoplasmic borders are prominent and there is a 
high cytoplasmic/nuclear ratio, with perinuclear clearing producing a halo 
effect. Nucleoli are often visible and do not correlate well with nuclear size. 
These tumours are characterised by diffuse cytoplasmic staining with 
Hale’s colloidal iron stain.(57) 
 Eosinophilic variant needs to be differentiated from oncocytoma as  both  
of them are considered to be derived from the intercalated cell of the 
collecting duct, both have alterations of mitochondria.(58) In addition, there 
are reports of hybrid tumor composed of oncocytic and chromophobe 
elements.   Cytogenetic and molecular studies show widespread loss of 
chromosomes and chromosomal regions with monosomy of chromosomes 
1, 2, 6, 10, 13, 17 and 21 being most frequent.. At the time of diagnosis 
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most patients are in the sixth decade, stage T1 or T2 (86%) and similar 
gender incidence.(59) 
 
5- Carcinoma of the collecting ducts of Bellini 
Collecting duct carcinoma (CDC) is centrally located in the kidney, ranges 
2.5 to 12 cm and typically shows a firm grey-white appearance. When 
small, origin within a medullary pyramid may be seen (60). Histologically 
they are composed of a mixture of dilated tubules and papillae lined by a 
single layer of cuboidal to columnar cells that often have a hobnail pattern.   
The cytoplasm is amphophilic to acidophilic. There is marked nuclear 
pleomorphism with vesicular to coarse chromatin and single or multiple 
nucleoli. mitosis is frequent with abnormal ones.  
Most tumors are in advanced stage with metastasis at diagnosis. The cells 
of CDC display Fuhrman iii and iv nuclear features. The main differential 
diagnoses of CDC include type 2 PRCC, renal pelvic adeno carcinoma or 
urothelial carcinoma with glandular differentiation. CDC accounts for <1% 
of renal malignancies and derives from the ‘‘principal cells’’ of the collecting 
duct. Mean patient age is 55 years with a slight male predominance. Upper 
tract imaging often suggests urothelial carcinoma and patients may have 
positive urine cytology.(61) 
 
6- Renal medullary carcinoma 
It is a rapidly growing rare tumor of the renal medulla regarded as an 
aggressive variant of CDC. With few exceptions this tumor is seen in young 
male blacks with sickle cell trait (mean age 22 years), presenting with 
hematuria, flank pain, weight loss and palpable mass. Metastatic deposits 
may be the initial clinical evidence. Prognosis is poor.(62) 
Histologically, the most characteristic feature is a reticular or yolk sac like 
appearance. Other patterns include solid nests or tubules. Infiltration by 
polymorphonuclear leukocytes is common. Tumor cells are pleomorphic, 
with large nuclei containing macronucleoli and with moderate to abundant 
acidophilic cytoplasm within desmoplastic stroma. 
 
7- Renal carcinoma associated with Xp11.2translocations/TFE3 gene 
fusions. 
This type of RCC is defined by different translocations involving 
chromosome Xp11.2, all resulting in gene fusions involving the TFE3 gene. 
This carcinoma predominantly affects children and young adults. The 
ASPL-TFE3 translocation carcinomas characteristically present at an 
advanced stage associated with lymph node metastases.(63) 
RCC associated with Xp11.2 translocations resemble clear cell RCC on 
gross examination and seems to have an indolent evolution, even with 
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metastasis. The histopathological appearance is that of a papillary 
carcinoma with clear cells and cells with granular eosinophilic cytoplasm. 
These cells display nuclear immunoreactivity for TFE3 protein. 
 
8- Renal cell carcinoma associated with neuroblastoma 
A few cases of RCC arise in long term survivors of childhood 
neuroblastoma. This group is heterogeneous, shows oncocytoid features.  
Allelic imbalances occur at the 20q1 locus. The prognosis is similar to other 
RCC. Males and females are equally affected with a mean age of 13.5 
years, being uni- or bilateral. 
 
9- Mucinous, tubular and spindle cell carcinoma 
This is a low-grade carcinoma composed of tightly packed tubules 
separated by pale mucinous stroma and a spindle cell component. It seems 
to derive from the distal nephron. This tumor has a combination of losses 
involving chromosomes 1, 4, 6, 8, 13 and 14 and gains of chromosome 7, 
11, 16 and 17.  There is a female predominance and the mean age is 53 
years. It presents as circumscribed asymptomatic mass on ultrasound 
examination. 
 
10- Renal cell carcinoma, unclassified 
In surgical series, it represents 4–6% of renal tumors and at presentation, 
most of them are of high grade and stage with poor survival. 
 Features which might place a carcinoma in this category include: 
(i) composites of recognised types, (ii) pure sarco-matoid morphology 
without recognisable epithelial elements, (iii) mucin production, (iv) rare 
mixtures of epithelial and stromal elements, and (v) unrecognizable cell 
types. 
 
Urothelial carcinomas of renal pelvis 
They represent about 5% to10% of primary renal tumors. 
Grossly tumors may be papillary, polypoid, nodular, ulcerative , or 
infiltrative. High grade tumors may appear as ill defined scirrhous mass that 
involve the renal parenchyma and may be multicenteric. 
Tumor grades either low grade or high grade depend on architectural and 
cytological features as their counterpart in the bladder. 
Prognosis depends on grading and staging (depth of invasion). 
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Squamous cell carcinoma 
They are more common in renal pelvis and ureter, next to urothelial 
carcinomas. These tumors are usually high grade and may invade the 
whole kidney. They grow in the back ground of nephrolithiasis with 
squamus metaplasia.(64-65) 
 
Tumors Metastatic to the kidney 
The most common primary sites of renal secondaries are lung, breast, skin 
(malignant melanoma) ,contra lateral kidney ,GIT, ovary and testes. 
In most cases metastases are multiple and bilateral with well circumscribed 
nodules, but they can also be single with infiltrative borders. 
Metastases may be limited to intra glomerular location, rarely resulting in 
renal failure. 
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1-9 Staging of renal cancer 
Tumor staging is a numerical description of the degree of invasion and 
metastic spread of the tumor. Staging of renal cancer is valuable both in 
treatment choice and as a prognostic factor.(66) 
Staging is based on the result of physical examinations, biopsies, imaging 
tests (CT scan, MRI, PET, and chest .x-ray. 
TNM classification  
TNM Definitions 
Primary tumor (T)  
• TX: Primary tumor cannot be assessed  
• T0: No evidence of primary tumor  
• T1: Tumor 7 cm or less in greatest dimension and limited to the 
kidney  
o T1a: Tumor 4 cm or less in greatest dimension and limited to 
the kidney  
o T1b: Tumor larger than 4 cm but 7 cm or less in greatest 
dimension and limited to the kidney 
• T2: Tumor larger than 7 cm in greatest dimension and limited to the 
kidney  
• T3: Tumor extends into major veins or invades adrenal gland or 
perinephric tissues but not beyond Gerota fascia  
o T3a: Tumor directly invades adrenal gland or perirenal and/or 
renal sinus fat but not beyond Gerota fascia  
o T3b: Tumor grossly extends into the renal vein or its segmental 
(i.e., muscle-containing) branches, or it extends into the vena 
cava below the diaphragm  
o T3c: Tumor grossly extends into the vena cava above the 
diaphragm or invades the wall of the vena cava 
• T4: Tumor invades beyond Gerota fascia  
Regional lymph nodes (N)*  
• NX: Regional lymph nodes cannot be assessed  
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• N0: No regional lymph node metastasis  
• N1: Metastasis in a single regional lymph node  
 
• N2: Metastasis in more than one regional lymph node  
*Laterality does not affect the N classification. 
If a lymph node dissection is performed, then pathologic evaluation would 
ordinarily include at least eight nodes.(67) 
Distant metastasis (M)  
• MX: Distant metastasis cannot be assessed  
• M0: No distant metastasis  
• M1: Distant metastasis  
AJCC Stage Groupings 
Stage I  
• T1, N0, M0  
Stage II  
• T2, N0, M0  
Stage III  
• T1 , N1, M0  
• T2, N1, M0  
• T3, N0 , M0  
• T3, N1, M0  
• T3a, N0, M0  
• T3a, N1, M0  
• T3b, N0, M0  
• T3b, N1, M0  
• T3c, N0, M0  
• T3c, N1, M0  
Stage IV  
• T4, N0, M0  
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• T4, N1, M0  
• Any T, N2, M0  
• Any T, any N, M1  
 
1-10 Grading 
Tumor grading is numerical expression of the degree of its cellular 
differentiation .It is based on careful assessment of histological section 
under the microscope .grading of renal cell carcinoma is based on  nuclear 
grade which is one of the most important prognostic feature of RCC(68). The 
preferred formulation is that of   Fuhrman nuclear grading system and is 
currently used for grading clear cell renal cell carcinoma (CCRCC), as 
follows: 
• Grade I: Nuclei are small (<10µm) and round, with dense chromatin 
and inconspicuous nucleoli.  
• Grade 2: Nuclei are slightly larger (15 µm) with finely granular 
chromatin and small nucleoli.  
• Grade 3: The nuclei are 20 µm in size and may be oval in shape, with 
coarsely granular chromatin and prominent nucleoli.  
• Grade 4: The nuclei are pleomorphic with open chromatin and single 
or multiple macro nucleoli. 
 
1-11 SCREENING FOR RCC: TARGET POPULATION 
1. Patients with end stage renal failure – Screen patients with long 
life expectancy by periodic ultrasound or CT, starting from 3rd year 
of dialysis.  
2. Patients with known VHL Syndrome: Biannual CT or Ultrasound 
beginning at 15-20 yrs, periodic radiographic screening for non 
renal manifestations. 
3. Relatives of patients with VHL: Obtain genetic analysis, if positive; 
follow screening for patients with VHL syndrome. 
4. Relatives of patients with other form of familial RCC periodic 
ultrasound and genetic analysis. 
5. Patient with Tuberous sclerosis: Periodic screening with ultrasound 
or CT - increased incidence of RCC in TS is debatable.(69) 
6. Patients with autosomal polycystic kidney disease: Screening not 
justified. 
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1-12 Treatment of renal cancer 
Renal cell carcinoma treatment varies from patient to patient. The 
treatment approach is adjusted to the patient’s needs and takes in 
consideration these following factors: (1) the renal cell carcinoma type, (2) 
the tumor size and location, (3) the cancer stage, (4) the general health 
state of the patient, and (5) the patient’s age.  
The treatment options for renal cell carcinoma patients include 
surgery, arterial embolization, chemotherapy, radiotherapy, hormone 
therapy, targeted therapy, and biological therapy. 
 
1-12-1Surgical treatment 
1-radical nephrectomy :  
 Considered as the gold standard treatment. It is include removal of 
the kidney, adrenal gland, peri renal fat, and Gerota fascia with or 
without regional lymph nodes resection. It is suitable for stage i, ii, iii, 
and some of iv.(70) 
2-Simple nephrectomy:  
Removal of the kidney only. 
3-Partial nepherctomy: 
usually use for stage I A tumors or patients with bilateral tumors 
,patients with only one kidney, patients who already had reduced 
kidney functions or patients with Hipple Lindau disease. 
 
1-12-2 Radiotherapy 
External-beam radiation therapy (EBRT):  is used befor , after 
nepherctomy  or as palliative therapy for selective patients. 
 
1-12-3 Arterial embolization 
May be employed pre operatively to reduce blood loss during 
nepherctomy or as palliative treatment in patients with inoperable 
disease. 
 
1-12-4 Biological therapy 
This cytokine therapy has been shown to induce objective response 
and have a modest  impact on survival in selected patients 
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.Interferon, inter leukine-2 or combination, cause the cancer cells to 
shrink and loose more than half  of their  original size in about 10%-
20% of the patients. 
 
 
 
1-12-5 Targeted therapy 
Anti angiogenic drugs, which block tyrosine kinase enzyme.   Sunitinib or 
Sorafenib (Nexavar). This is a drug which blocks the new blood vessel 
from growing and the growth-stimulating molecules within the cancerous 
cell. It has proven to be effective in advanced stages renal cell carcinoma 
patients by slowing down the cancer progression.(71) 
 
1-12-6 Chemo therapy 
Unfortunately, kidney cancer cells are usually resistant to chemotherapy, 
and there is no standard way to treat it with these drugs. Some drugs, 
such as vinblastine, floxuridine, 5-fluorouracil (5-FU), capecitabine, and 
gemcitabine have been shown to help a small number of patients. Still, 
chemotherapy is often reserved for cancers in which targeted drugs 
and/or immunotherapy are not effective.(72) 
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1-13 Prognosis 
Depends on 
1. Pathological stage 
2. Tumor size  
3. Nuclear grade  
 
Histological subtype prove to be important prognostic factors.(73-74) 
 
Prognosis – RCC / Radical Nephrectomy  
A tumor confined to the kidney is associated with a better prognosis.  
Stage I - 5-year survival rate is approximately 94%,  
Stage II - Survival rate of 79%.  
Stage III - IIIB renal cell carcinoma is 18%. 
Stage IV 0 - 20% 
Surgical removal of renal vein or IVC thrombus – 5-yr survival 25 -50%, 
15-20% reduction in survival over 5 year with invasion of perinephric fat. 
Systemic metastasis 1 year survival rate less than 50%.  
Patients with clear cell renal cell carcinoma (CCRCC) tend to have a worse 
prognosis than patients with other histological subtypes of renal cell 
carcinoma (RCC), with 5-year disease-specific survival rates of 50-69%, 
compared with 67-87% for papillary renal cell carcinoma (RCC) and 78-
87% for chromophobe RCC (chRCC). However, analysis of 1000 patients 
showed very similar 5-year disease-specific survival rates for clear cell 
renal cell carcinoma (10.5%) and papillary renal cell carcinoma (10.3%) 
once metastatic disease was present.(75) 
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Objectives 
 
 
 
 
 
General Objectives: 
 
To study the cases with renal cancer in the study area from January 2007 
to August 2010, with the objective to determine the different 
epidemiological & clincopathological features of this disease. 
 
 
 
 
Specific Objectives: 
 
1. To review the histological patterns of renal cancer among the study 
population. 
2. To determine the frequencies of nuclear grades of renal cancer 
according to Fuhrman grading system among the study population. 
3. To determine the different stages of renal cancer according to TMN 
classification system. 
4. To review the clinical presenting features of renal cancer in the study 
population. 
5. To determine the relation between histological patterns and age, sex 
and site of tumor. 
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Chapter Two 
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Methodology 
2.1 Study design: 
 The study is a descriptive retrospective recorded data-based study. 
2.2 Study area: 
The study was conducted at different departments of histopathology 
including Ibn Sina hospital, Soba teaching hospital, Khartoum teaching 
hospital & National health laboratory (NHL). 
2.3 Study population: 
Cases diagnosed as renal cancer in the study area from Jan 2007 up to 
Aug 2010. 
2.4 Inclusion criteria: 
Cases of renal cancer with full records and histopathological slides. 
2.5 Exclusion criteria: 
Cases with deficient records (missed request forms) or missed 
histopathological slides and blocks.. 
2.6 Data collection: 
Data were collected from the patients request forms and patients files 
including detailed personal, clinical and pathological data. The slides were 
collected and reviewed by expert histopathologist to confirm the diagnosis 
of renal cancer, to determine the histological type using the WHO 
classification of renal cancer and to grade the tumor using Fuhrman 
grading system (nuclear grading depends on nuclear size, shape of the 
chromatin & presence of nucleoli so it was graded into four grades which 
have prognostic effects) was applied in this study. And lastly tumor staging 
using the TNM system (depend on the tumor size, lymph node involvement 
and the degree of invasion and metastases) was applied for this study. 
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2.7 Data analysis & statistics: 
 The data were analyzed by SPSS software. 
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Chapter Three 
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Results 
The total number of patients with renal cancer during the study period was 
117 patients; 6 of them had missed slides and consequently excluded from 
the study. The remainders (111) patients were selected and studied. 
3.1 Characteristics of the studied patients: 
3.1.1 Age distribution: 
 The age of the studied patients ranged from 19 to 86 years, with a 
mean of 52.72 years +-.The age group with highest frequency was (46 – 
60) years (Figure 1). 
3.1.2 Sex distribution of the patients: 
 Fifty nine patients (53.2%) of the patients were males, compared to 
fifty two (48.8%) females (Figure 2). Thus, the male to female ratio was 1.31:1 
3.1.3 Residence distribution of patients with renal cancer: 
 Concerning the residence of patients, sixty eight (64% ) of them came 
from central regions including Khartoum and the four central states. Five 
(4.8%) patients were from the northern region. The west, east & south were 
represented with five (4.8%), five (4.8%) and one (1%) respectively. In 
twenty one patients (20% of the cases) the residency was not stated in the 
request form (Figure 3). 
3.2 Distribution of the clinical symptoms among studied patients: 
 The various clinical presentations of the renal cancer in the studied 
group were shown in table (1). Thirty seven patients had loin pain (35.2%), 
abdominal mass in thirty three patients (31.4%). Haematuria in twenty four 
patients (22.9%) and five patients were diagnosed by incidental ultra sound  
Other complaints  : loss of weight ,fever ,bilateral hydro nepherosis and 
pleural effusion were observed in four patients (3.8%).(table1) 
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3.3 Site distribution of the renal cancer 
 Figure (4) demonstrates the site distribution of the renal cancer in the 
studied patients. Right sided & left sided cancer was found (45%) & 
(54.1%) respectively, no information concerning the site was given in 
(0.9%) of the set-up. 
3.4 Mode of operation among Population Study 
 Three modes of operation were used to obtain the specimen from the 
studied patients. The most frequently used procedure was nephrectomy in 
92 patients (87.61%), partial nephrectomy in 2 patients (1.8%) and core 
needle biopsy in 11 patients (9.9%) of the cases.(figure 5) 
3.5 Histopathological characteristics of RCC among the studied 
patients 
3.5.1 Histological types: 
The diagnosis of renal cancer in this study is based solely on the 
histopathological examination of the surgical specimens. 
The vast majority (94.6%) was RCC, while transitional cell carcinoma 
(4.5%) & squamous cell carcinoma in (0.9%) of the cases (table 3). Clear 
cell RCC was the predominant histological subtype seen in (71.2%) of 
cases, secondly comes papillary carcinoma (18%), sarcomatoid carcinoma 
(3.8%), chromphobe (0.9%) and collecting duct carcinoma (0.9%)  
3.5.2 Grading: 
Fuhrman grading system (nuclear grading) was applied in this study. The 
majority of cases (44.1%) 48 patients were considered as grade II, followed 
by grade III (26%) 29 patients, grade I (15.3%) 16 patients and lastly grade 
IV (14.4%) in 12 of patients (Table2) 
3.5.3 Staging:  
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Clinical Presentation of Renal Cancer Among the Study Population  
Clinical Presentation Frequency Percentage 
Loin pain 37 35.2% 
Abdominal mass 33 31.4% 
Haematuria 24 22.9% 
Incidental U\S 5 4.8% 
Other complains 4 3.8% 
Not mentioned 2 2.9% 
Total 105 100% 
 
 
 
 
 
 
 
 
 
 
 
54 
 
 
 
 
 
 
 
 
 
 
 
Grading Scores for Renal Cell Carcinoma Among the Study 
Population 
 Grade Frequency Percentage 
I 16 15.02% 
II 48 45.7% 
III 29 27.6% 
Iv 12 11.4% 
Total 105 100% 
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Staging Scores for Renal Cell Carcinoma Among the Study 
Population 
 Stage Frequency Percentage 
I 13 12-4% 
II 30 28-6% 
III 41 39% 
Iv 8 7-6% 
Not applicable 13 12-4% 
Total 105 100% 
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Histological Types Among the Study Population 
Histological Type Frequancy Percent 
RCC clear cell 
 
79 71.2 
RCC papillary 
 
20 18.0 
RCC sarcomatoid 
 
4 3.6 
RCC chromphobe 
 
1 0.9 
Collecting duct 
 
1 0.9 
Transitional cell carcinoma 
 
5 4.5 
Squamous cell carcinoma 
 
1 0.9 
Total 
 
111 100 
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Relationship Between Histological Types & Gender of the Patients 
Histological Type Gender Total 
Male Female 
RCC clear cell  41  
(51.9%) 
38  
(48.1%) 
79    
(100%) 
RCC papillary 11  
(55%) 
9    
(45%) 
20    
(100%) 
RCC sarcomatoid 3    
(75%) 
1    
(25%) 
4      
(100%) 
RCC chromophobe 0   
 (0%) 
1   
 (100%) 
1      
(100%) 
Collecting duct 1   
 (100%) 
0   
 (0%) 
1     
 (100%) 
Total 56  
(53.3%) 
49  
(46.7%) 
105 
 (100%) 
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Relationship Between Histological Types & the Site of the Tumor 
Histological Type Site Total 
Right Left 
RCC clear cell 32  
 (41%) 
46  
 (59%) 
78    
(100%) 
RCC papillary 10  
 (50%) 
10  
 (50%) 
20    
(100%) 
RCC sarcomatoid 1     
(25%) 
3    
 (75%) 
4     
 (100%) 
RCC chromophobe 1     
(100%) 
0   
  (0%) 
1   
   (100%) 
Collecting duct 1    
 (100%) 
0    
 (0%) 
1    
  (100%) 
Total 45  
 (43.3%) 
59  
 (56.7%) 
104   
(100%) 
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Relationship Between Histological Types & the Age of Patients 
Histological 
Type 
Age Groups Total 
16-30 31-45 46-60 61-75 76-90 
RCC clear cell 8 
(10.4%) 
18 
(23.4%)
32 
(41.6%)
18 
(23.4%)
1  
(1.3%) 
77      
(100%) 
RCC papillary 1   
(5.6%) 
4 
(22.2%)
7 
(38.9%)
5 
(27.8%)
1  
(5.6%) 
18      
(100%) 
RCC sarcomatoid 1   
(25%) 
1   
(25%) 
1   
(25%) 
1   
(25%) 
0     
(0%) 
4         
(100%) 
RCC 
chromophobe 
0     
(0%) 
0     
(0%) 
1 
(100%) 
0     
(0%) 
0     
(0%) 
1 
(100%) 
Collecting duct 0     
(0%) 
0     
(0%) 
0     
(0%) 
1 
(100%) 
0     
(0%) 
1 
(100%) 
Total 10 
(9.9%) 
23 
(22.8%)
41 
(40.6%)
25 
(24.8%)
2 
(2%) 
101 
(100%) 
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Relationship Between Histological Types & clinical Stages Among the 
Study Population 
Histological 
Type 
Stage Total 
Stage I Stage II Stage III Stage IV 
RCC clear cell 10 
(14.1%) 
21 
(29.6%) 
32 
(45.1%) 
8 
(11.3%) 
71 
(100%) 
RCC papillary 2 
(12.5%) 
7 
(43.8%) 
7 
(43.8%) 
0 
(0%) 
16 
(100%) 
RCC sarcomatoid 0 
(0%) 
2 
(50%) 
2 
(50%) 
0 
(0%) 
4 
(100%) 
RCC 
Chromophobe 
1 
(100%) 
0 
(0%) 
0 
(0%) 
0 
(0%) 
1 
(100%) 
Total 13 
(14.1%) 
30 
(32.6%) 
41 
(44.6%) 
8 
(8.7%) 
92 
(100%) 
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Relationship Between Histological Types & Furhman Grade Among 
the Study Population 
Histological 
Type 
Furhman Grade Total 
Grade I Grade II Grade III Grade IV 
RCC clear 
cell 
15 
(19%) 
34 
(43%) 
22 
(27.8%) 
8 
(10.1%) 
79 
(100%) 
RCC papillary 1 
(5%) 
14 
(70%) 
5 
(25%) 
0 
(0%) 
20 
(100%) 
RCC 
sarcomatoid 
0 
(0%) 
0 
(0%) 
1 
(25%) 
3 
(75%) 
4 
(100%) 
RCC 
Chromophobe 
0 
(0%) 
0 
(0%) 
0 
(0%) 
1 
(100%) 
1 
(100%) 
Collecting 
duct 
0 
(0%) 
0 
(0%) 
1 
(100%) 
0 
(0%) 
1 
(100%) 
Total 16 
(15.2%) 
48 
(45.7%) 
29 
(27.6%) 
12 
(11.4%) 
100 
(100%) 
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Discussion 
This is a retrospective descriptive study on renal cancer in Sudanese 
patients; it was carried out in the period from January 2007 to August 2010. 
This study has been faced by many difficulties and limitations due to 
deficient registration data, in particular the poor information regarding 
history and clinical information and in some labs the filing of records and 
slides was poor, so it is very difficult to compare this result with the 
international data especially in defining the risk factors. 
There has been a significant increase in all cancers incidence all over the 
world and in Sudan as one of the African and developing countries a sharp 
increase in all types of cancer including renal cancer .(9,10) 
Regarding the age in this study, the mean age of the patients was 52.72 
years it is about three years younger than the age of fifty five years in the 
USA and other European countries, RCC was found more frequently in the 
age group (46 – 60) years and 31.4% of the patients was under 46 years 
old. 
This observation should alert the clinicians in Sudan to be more cautious in 
managing patients with urinary symptoms or patients with renal mass as 
malignant neoplasm’s are more common than benign ones. 
In this study the sex distribution of RCC shows high female to male ratio as 
it is 1.13:1 while in most western countries and USA the ratio is 2:1 to 
1.5:1.(1,6) 
The study shows no relation between the gender of the patient and the 
histological types. 
71 
 
Regarding the residency the majority (64%) of patients came from central 
regions – including the capital Khartoum and the four centre states -. The 
least frequent place of origin has been the most remote states. This can 
readily be explained on the bases of the demographic and economic 
characteristics of the Sudanese population, in that most Sudanese are 
clustered in the big towns and also the unjustified focusing of the medical 
services in the capital.  
Regarding the occurrence of RCC was almost in equal rates between right 
and left kidney as observations shows left kidney 46.73% and right 43.27%, 
and this shows a clear similarity with the literature. 
The present study found that about 92% of cases had symptoms at the 
time of diagnoses while in the literature is less than 20%(1); this is very 
alarming because most symptomatic patients of RCC have advanced 
disease. 
 In USA and western countries RCC is known as a radiologist tumor and as 
more than 60% of them are diagnosed indecently so they named it incident 
loma, so this must give another alert for the clinicians and radiologists. 
The study showed three modes of diagnostic procedures were used, the 
most frequently used procedure was total nephrectomy in 92 patients 
(87.61%) followed by needle biopsy in 11 patients (9.9%) and lastly partial 
nephrectomy in 2 patients (1.9%), this is due to the advanced stage of the 
diagnosed patients. 
The low percentage of needle biopsy as a diagnostic procedure may be 
due to the low awareness of renal cell carcinoma. 
On the view of the limitations of this study the histological types showed the 
highest frequency of RCC (94.6%) and this has some agreement with the 
international data. 
When we take a look at the sub-types of RCC the commonest is the 
conventional clear cell type (71.2%) followed by papillary type (18%), 
sarcomatoid (3.8%) and equal percentage of Chromophobe & collecting 
duct carcinoma (0.9%) each .these are similar to literature except for the 
lower percentage of chromophobe as it is about 5%in most studies.(1,57) 
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Five patients (4.5%) were diagnosed as transitional cell carcinoma three of 
them are males and two are females ,their age range between 55 to 70 
years, three of them present  with hematuria. By usining the WHO grading 
system for urothelial tumors , three were graded as high grade while the 
other two were low grade.  
One patient (0.9%) as squamous cell carcinoma which is a rare type but 
there is some reported cases. 
Most of the cases in this study were considered as grade II followed by 
grade III in Fuhrman grading system, this also highlights the 
aggressiveness of the types of RCC. 
By using the TNM staging system the study showed that the majority of the 
cases are stage III followed by stage II, this is another clue for the advance 
stage of RCC at the time of diagnoses. 
Unfortunately this study could not assess the importance of the different 
risk factors of RCC due to the deficiency of recorded data, although some 
patients have some risk factors such as hypertension, one patient with 
chronic renal failure on chronic dialysis and another patient with family 
history of renal cancer in her mother. So further heavy work is needed to 
identify the natural history of renal cancer in Sudan and this means team 
work including clinicians, radiologists, histopathologist and oncologists.      
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Conclusion 
 
This is study on Renal cell cancer ,with all the difficulties and limitations, it 
indicated that this type of cancer is common and have some  similar  
pathological and clinical   features with other countries. 
These features include younger age group, high female: male ratio late 
presentation with advanced disease. 
The study identified five sub types of RCC, transtional cell carcinoma and 
squamous cell carcinoma. 
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Recommendations 
 
Renal cancer needs more studies and hard works, especial concentration 
on the risk factors (environmental, community related and familial ones. ) 
Cooperation and coordination between clinicians and pathologists for early 
detection and mangement.   
Improvements of blocks and slide storage. 
Use of very strict rejection criteria regarding the request forms. 
Improvement of cancer registry all over the country. 
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